Exosomes and Conventional Outflow Homeostasis
外泌体和常规流出稳态
基本信息
- 批准号:10737784
- 负责人:
- 金额:$ 24.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2025-12-31
- 项目状态:未结题
- 来源:
- 关键词:AnteriorAqueous HumorAreaBindingBiologyCellsCellular biologyCorneaCytoskeletonDataDiseaseElementsEnvironmentEquilibriumExperimental DesignsExposure toExtracellular MatrixExtracellular Matrix ProteinsEyeFeedbackFibroblastsFibronectinsFibrosisFlow CytometryFunctional disorderGene ExpressionGenesGlaucomaHomeostasisHumanImmunofluorescence ImmunologicIn SituIn VitroIntegrinsInterruptionLabelMaintenanceMalignant NeoplasmsMatrix MetalloproteinasesMechanicsMediatingMentorsMethodsMicroRNAsMonitorOcular HypertensionOrgan Culture TechniquesOutcomes ResearchPathway interactionsPatternPerfusionPhasePhenotypePhysiologic Intraocular PressureProcessProductionProteomicsRegulationRejuvenationResearchResistanceRho-associated kinaseRisk FactorsRoleStretchingTechniquesTherapeuticTissuesTrabecular meshwork structureTracerTrainingWaste Managementcell typedesigndifferential expressionex vivo perfusionexosomeextracellularextracellular vesiclesintercellular communicationkinase inhibitornanosizednanovesiclenatural flownoveloptic nerve disorderrepairedskillstheories
项目摘要
Project Summary
Glaucoma is an optic neuropathy in which the primary risk factor is elevated intraocular pressure (IOP).
Dysregulation of conventional outflow homeostasis results in elevated IOP. Key elements of outflow homeostasis
are the turnover of extracellular matrix (ECM), which also determines preferential flow passageways through the
tissue. In fact, there is recent evidence of differential ECM gene expression between regions of low and high
flow in the trabecular meshvvork (TM). In cancer, dysregulation of ECM homeostasis has been demonstrated to
involve extracellular nanovesicles, known as exosomes. Exosome release is tightly regulated, and they are
differentiated from other nanovesicles based on their size, cell type-specific function and cargo. Amongst others,
their functions include waste management, cell-cell signaling and ECM turnover. As a result, we hypothesize
that exosomes released from TM cells play a role in opsonizing ECM in the outflow pathway, contributing
to segmental flow, and altered ECM homeostasis in glaucoma. This study aims to investigate the role of
exosomes in regulating ECM by human TM cells and in TM tissues. During the independent phase, I will examine
how IOP effects exosome release and regulation in the conventional outflow pathway in terms of segmental flow.
Next, using human TM cells and TM tissues, I will investigate how exosomes can be used to ameliorate a
glaucoma phenotype and ocular hypertension. As outcomes of this research we expect to (i) identify a role for
exosomes in segmental flow (ii) determine the effect of IOP on exosome release and function (iii) identify ECM
targets for exosome regulation and, (iv) ascertain if exosomes can be used to normalize ECM homeostasis.
项目概要
青光眼是一种视神经病变,其主要危险因素是眼内压(IOP)升高。
常规流出稳态的失调导致眼压升高。流出稳态的关键要素
是细胞外基质(ECM)的周转率,它也决定了通过细胞的优先流动通道
组织。事实上,最近有证据表明低和高区域之间的 ECM 基因表达存在差异。
小梁网 (TM) 中的血流。在癌症中,ECM 稳态失调已被证明
涉及细胞外纳米囊泡,称为外泌体。外泌体的释放受到严格调控,并且
根据其大小、细胞类型特异性功能和货物与其他纳米囊泡的区别。其中,
它们的功能包括废物管理、细胞间信号传导和 ECM 周转。因此,我们假设
TM 细胞释放的外泌体在流出途径中调理 ECM 中发挥作用,有助于
节段血流,并改变青光眼的 ECM 稳态。本研究旨在调查的作用
外泌体通过人类 TM 细胞和 TM 组织调节 ECM。在独立阶段,我会检查
IOP 如何影响外泌体在传统流出途径中的节段流释放和调节。
接下来,我将使用人类 TM 细胞和 TM 组织,研究如何使用外泌体来改善
青光眼表型和高眼压症。作为这项研究的结果,我们期望 (i) 确定以下角色:
分段流中的外泌体 (ii) 确定 IOP 对外泌体释放和功能的影响 (iii) 识别 ECM
外泌体调节的目标,以及(iv)确定外泌体是否可用于使 ECM 稳态正常化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Fiona McDonnell其他文献
Fiona McDonnell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Fiona McDonnell', 18)}}的其他基金
相似海外基金
The role of distal aqueous humor outflow tissue in glucocorticoid-induced glaucoma
远端房水流出组织在糖皮质激素诱发青光眼中的作用
- 批准号:
10667863 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Validation of an aqueous humor liquid biopsy for molecular prognostication and monitoring of children with retinoblastoma.
房水液体活检对视网膜母细胞瘤儿童分子预测和监测的验证。
- 批准号:
10718932 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Regulation of aqueous humor flow by exosomal miRNA
外泌体 miRNA 对房水流动的调节
- 批准号:
23K09011 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of experimental basis to improve the prognosis of corneal transplantation in treating bullous keratoplasty due to pathological aqueous humor.
为改善角膜移植治疗病理性房水所致大疱性角膜移植术的预后奠定实验基础。
- 批准号:
23H03063 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating aqueous humor outflow with engineered nanoparticles for glaucoma
用工程纳米颗粒调节房水流出以治疗青光眼
- 批准号:
10649763 - 财政年份:2023
- 资助金额:
$ 24.9万 - 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
- 批准号:
10510279 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Single cell transcriptome profiling of aqueous humor outflow development for discovery of novel childhood glaucoma genes
房水流出发育的单细胞转录组分析以发现新的儿童青光眼基因
- 批准号:
10682543 - 财政年份:2022
- 资助金额:
$ 24.9万 - 项目类别:
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
- 批准号:
10155489 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
ocular tissue response by intraocular pressure and aqueous humor in glaucoma - investigation for the mechanism and biomarkers of intraocular pressure regulation
青光眼中眼压和房水引起的眼组织反应——眼压调节机制和生物标志物的研究
- 批准号:
20H03839 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Dynamic Variable Aqueous Humor Outflow and Glaucoma Therapies in the Human Eye
人眼的动态可变房水流出和青光眼治疗
- 批准号:
10405079 - 财政年份:2020
- 资助金额:
$ 24.9万 - 项目类别: